Osborne Clarke has advised neuroClues®. neuroClues®, a European MedTech company powered by P3Lab SRL, has completed a €10 million Series A investment round. The funding round…
neuroClues® Secures €10 Million in Series A Fundraising for AI-Powered Neurological Biomarkers Expansion

























